ME00592A - Postupak liječenja termoregulacione disfunkcije paroksetinom - Google Patents

Postupak liječenja termoregulacione disfunkcije paroksetinom

Info

Publication number: ME00592A
Authority: ME; Montenegro
Prior art keywords: paroxetine; heat; waves; menopause; disfunction
Prior art date: 2006-08-04

Application number

MEP-37/09A

Other languages

Bosnian (bs)

English (en)

Inventor

Patricia Allison Tewes Richards

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-04

Filing date

2007-07-31

Publication date

2011-12-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39030027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00592(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-07-31 Application filed filed Critical

2011-12-20 Publication of ME00592A publication Critical patent/ME00592A/hr

2011-12-20 Publication of ME00592B publication Critical patent/ME00592B/me

Links

230000001331 thermoregulatory effect Effects 0.000 title abstract 2
AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
229960002296 paroxetine Drugs 0.000 title 1
230000003054 hormonal effect Effects 0.000 abstract 2
230000009245 menopause Effects 0.000 abstract 2
208000033830 Hot Flashes Diseases 0.000 abstract 1
206010060800 Hot flush Diseases 0.000 abstract 1
230000036760 body temperature Effects 0.000 abstract 1
230000004064 dysfunction Effects 0.000 abstract 1
206010029410 night sweats Diseases 0.000 abstract 1
230000036565 night sweats Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MEP-2009-37A 2006-08-04 2007-07-31 Postupak lečenja termoregulacione disfunkcije paroksetinom ME00592B (me)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11/499,586 US20080033050A1 (en)	2006-08-04	2006-08-04	Method of treating thermoregulatory disfunction with paroxetine
PCT/US2007/017062 WO2008019010A2 (en)	2006-08-04	2007-07-31	Method of treating thermoregulatory disfunction with paroxetine

Publications (2)

Publication Number	Publication Date
ME00592A true ME00592A (hr)	2011-12-20
ME00592B ME00592B (me)	2011-12-20

Family

ID=39030027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-2009-37A ME00592B (me)	2006-08-04	2007-07-31	Postupak lečenja termoregulacione disfunkcije paroksetinom

Country Status (27)

Country	Link
US (7)	US20080033050A1 (hr)
EP (2)	EP2068881B1 (hr)
JP (2)	JP5846717B2 (hr)
KR (3)	KR20140098865A (hr)
CN (1)	CN101505759A (hr)
AU (1)	AU2007282065B2 (hr)
BR (1)	BRPI0715087A2 (hr)
CA (1)	CA2659577C (hr)
CY (2)	CY1120867T1 (hr)
DK (2)	DK2068881T3 (hr)
ES (2)	ES2698207T3 (hr)
HR (2)	HRP20181893T1 (hr)
HU (2)	HUE040099T2 (hr)
IL (1)	IL196844A (hr)
LT (2)	LT2719385T (hr)
ME (1)	ME00592B (hr)
MX (1)	MX2009001275A (hr)
NO (1)	NO343176B1 (hr)
NZ (1)	NZ574735A (hr)
PL (2)	PL2719385T3 (hr)
PT (2)	PT2068881T (hr)
RS (2)	RS58046B1 (hr)
RU (1)	RU2478379C2 (hr)
SG (1)	SG176452A1 (hr)
SI (2)	SI2719385T1 (hr)
UA (1)	UA96770C2 (hr)
WO (1)	WO2008019010A2 (hr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080033050A1 (en)	2006-08-04	2008-02-07	Richards Patricia Allison Tewe	Method of treating thermoregulatory disfunction with paroxetine
US9211290B2 (en) *	2012-12-31	2015-12-15	Noven Therapeutics, Llc	Solid dispersions of amorphous paroxetine mesylate
CN107249615B (zh) *	2015-04-07	2021-02-05	株式会社明治	潮热抑制剂
KR102817311B1 (ko)	2016-09-29	2025-06-09	(주)아모레퍼시픽	젖산을 유효성분으로 포함하는 열성홍조 개선용 건강식품 조성물

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
GB8520154D0 (en) *	1985-08-10	1985-09-18	Beecham Group Plc	Chemical process
EP0223403B1 (en) *	1985-10-25	1993-08-04	Beecham Group Plc	Piperidine derivative, its preparation, and its use as medicament
GB8714707D0 (en) *	1987-06-23	1987-07-29	Beecham Group Plc	Chemical process
GB9325644D0 (en) *	1993-12-15	1994-02-16	Smithkline Beecham Plc	Novel formulation
US5470846A (en) *	1994-01-14	1995-11-28	Sandyk; Reuven	Treatment of neurological and mental disorders
JPH0837567A (ja)	1994-07-26	1996-02-06	Olympus Optical Co Ltd	情報記録媒体及び情報再生装置
US5856493A (en) *	1995-02-06	1999-01-05	Smithkline Beecham Corporation	Process for making novel form of paroxeting hydrochloride anhydrate
SE9501567D0 (sv) *	1995-04-27	1995-04-27	Astra Ab	A new combination
US6548084B2 (en) *	1995-07-20	2003-04-15	Smithkline Beecham Plc	Controlled release compositions
JP3882224B2 (ja) *	1996-05-31	2007-02-14	旭硝子株式会社	パロキセチンの製造方法
US6638948B1 (en)	1996-09-09	2003-10-28	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
US5672612A (en) *	1996-09-09	1997-09-30	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
CA2193939C (en) *	1996-12-24	2002-02-12	K.S. Keshava Murthy	Useful form of anhydrous paroxetine hydrochloride
GB9700690D0 (en) *	1997-01-15	1997-03-05	Smithkline Beecham Plc	Novel process
GB9710004D0 (en) *	1997-05-17	1997-07-09	Knoll Ag	Chemical process
US5910319A (en) *	1997-05-29	1999-06-08	Eli Lilly And Company	Fluoxetine enteric pellets and methods for their preparation and use
BR9809687A (pt) *	1997-05-29	2000-07-11	Smithkline Beecham Corp	Processo novo
AU3108097A (en) *	1997-06-10	1998-12-30	Synthon B.V.	4-phenylpiperidine compounds
US5955475A (en) *	1997-06-30	1999-09-21	Endo Pharmaceuticals Inc.	Process for manufacturing paroxetine solid dispersions
SE9900190D0 (sv) *	1999-01-22	1999-01-22	Astra Ab	New compounds
SE9702799D0 (sv) *	1997-07-25	1997-07-25	Astra Ab	New compounds
US6133277A (en) *	1997-12-05	2000-10-17	Janssen Pharmaceutica N.V.	(Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
EA200000890A1 (ru)	1998-03-02	2001-02-26	Эли Лилли Энд Компани	Гидрохлорид флуоксетина для уменьшения "приливов" (приступообразных ощущений жара (при климактерическом синдроме))
PL342931A1 (en)	1998-03-16	2001-07-16	Smithkline Beecham Plc	Crystalline form of paroxetine
US6699882B2 (en) *	1998-03-24	2004-03-02	Smithkline Beecham P.L.C.	Paroxetine compositions
US20030028027A1 (en) *	1998-04-09	2003-02-06	Smithkline Beecham Plc	Paroxetine maleate
JP3796351B2 (ja) *	1998-04-13	2006-07-12	住友化学株式会社	パロキセチン塩酸塩無水和物の乾燥方法
US6168805B1 (en) *	1998-05-07	2001-01-02	Endo Pharmaceuticals, Inc.	Aqueous process for manufacturing paroxetine solid dispersions
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) *	1998-07-07	2000-10-01	Medichem Sa	Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
ES2159260B1 (es) *	1999-06-22	2002-05-01	Smithkline Beechan Plc	Nueva composicion de metanosulfonato de paroxetina
US6369051B1 (en) *	2000-07-06	2002-04-09	American Home Products Corporation	Combinations of SSRI and estrogenic agents
US6660298B1 (en) *	2000-07-27	2003-12-09	Pentech Pharmaceuticals, Inc.	Paroxetine tablets and capsules
CA2418038A1 (en)	2000-08-28	2002-03-07	Synthon B.V.	Paroxetine compositions and processes for making the same
US6498184B2 (en) *	2000-12-05	2002-12-24	Akzo Nobel N.V.	Serotonergic compound for a method of treatment of hot flushes in post-menopausal women
NZ526874A (en) *	2001-01-04	2005-07-29	Ferrer Internacional S	Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
DE20100529U1 (de)	2001-01-11	2001-05-10	Synthon Bv	Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) *	2001-02-21	2002-01-15	Synthon Bv	Werkwijze voor het vervaardigen van paroxetine.
EP1266659A1 (en)	2001-06-11	2002-12-18	Pantarhei Bioscience B.V.	Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
US6956121B2 (en) *	2002-03-01	2005-10-18	Teva Pharmaceutical Industries Ltd.	Preparation of paroxetine involving novel intermediates
EP1530476A1 (en) *	2002-08-14	2005-05-18	Pharmacia & Upjohn Company LLC	Use of reboxetine for the treatment of hot flashes
US20040152710A1 (en)	2002-10-15	2004-08-05	Deecher Darlene Coleman	Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
ITMI20022344A1 (it) *	2002-11-05	2004-05-06	Biofarm Srl	Prodotto in pellicola a rapida dissoluzione in acqua, per il trattamento del latte con batteri e/o enzimi.
TWI267838B (en) *	2003-01-03	2006-12-01	Lite On It Corp	Method to detect the type of optical disk
US20050130987A1 (en)	2003-10-14	2005-06-16	Wyeth	Methods of treating vasomotor symptoms
RU2007102292A (ru) *	2004-07-22	2008-08-27	Вайет (Us)	Способ лечения расстройств и заболеваний нервной системы
MX2007000851A (es) *	2004-07-22	2007-03-26	Wyeth Corp	Procedimiento para el tratamiento de trastornos y dolencias del sistema nervioso.
US20060100263A1 (en) *	2004-11-05	2006-05-11	Anthony Basile	Antipyretic compositions and methods
KR100764679B1 (ko)	2005-07-22	2007-10-09	익수제약 주식회사	파록세틴을 함유하는 경피투여용 패취제
CN101325944B (zh) *	2005-10-11	2013-01-16	耶路撒冷希伯来大学伊萨姆研究开发公司	用于鼻部给药的组合物
US20080033050A1 (en)	2006-08-04	2008-02-07	Richards Patricia Allison Tewe	Method of treating thermoregulatory disfunction with paroxetine

2006
- 2006-08-04 US US11/499,586 patent/US20080033050A1/en not_active Abandoned
2007
- 2007-07-31 SI SI200732079T patent/SI2719385T1/sl unknown
- 2007-07-31 HU HUE13190594A patent/HUE040099T2/hu unknown
- 2007-07-31 BR BRPI0715087-3A2A patent/BRPI0715087A2/pt not_active Application Discontinuation
- 2007-07-31 HR HRP20181893TT patent/HRP20181893T1/hr unknown
- 2007-07-31 EP EP07810919.6A patent/EP2068881B1/en active Active
- 2007-07-31 DK DK07810919.6T patent/DK2068881T3/en active
- 2007-07-31 MX MX2009001275A patent/MX2009001275A/es unknown
- 2007-07-31 PL PL13190594T patent/PL2719385T3/pl unknown
- 2007-07-31 AU AU2007282065A patent/AU2007282065B2/en not_active Ceased
- 2007-07-31 LT LTEP13190594.5T patent/LT2719385T/lt unknown
- 2007-07-31 LT LTEP07810919.6T patent/LT2068881T/lt unknown
- 2007-07-31 HU HUE07810919A patent/HUE040481T2/hu unknown
- 2007-07-31 PT PT07810919T patent/PT2068881T/pt unknown
- 2007-07-31 CN CNA2007800289306A patent/CN101505759A/zh active Pending
- 2007-07-31 CA CA2659577A patent/CA2659577C/en active Active
- 2007-07-31 RU RU2009107739/15A patent/RU2478379C2/ru not_active IP Right Cessation
- 2007-07-31 PL PL07810919T patent/PL2068881T3/pl unknown
- 2007-07-31 UA UAA200901871A patent/UA96770C2/uk unknown
- 2007-07-31 JP JP2009522831A patent/JP5846717B2/ja not_active Expired - Fee Related
- 2007-07-31 KR KR1020147020772A patent/KR20140098865A/ko not_active Ceased
- 2007-07-31 DK DK13190594.5T patent/DK2719385T3/en active
- 2007-07-31 KR KR1020097004195A patent/KR20090040453A/ko not_active Ceased
- 2007-07-31 KR KR1020157032729A patent/KR20150132888A/ko not_active Ceased
- 2007-07-31 ME MEP-2009-37A patent/ME00592B/me unknown
- 2007-07-31 RS RS20181386A patent/RS58046B1/sr unknown
- 2007-07-31 NZ NZ574735A patent/NZ574735A/en not_active IP Right Cessation
- 2007-07-31 ES ES07810919T patent/ES2698207T3/es active Active
- 2007-07-31 SG SG2011081056A patent/SG176452A1/en unknown
- 2007-07-31 SI SI200732071T patent/SI2068881T1/sl unknown
- 2007-07-31 ES ES13190594T patent/ES2699298T3/es active Active
- 2007-07-31 PT PT13190594T patent/PT2719385T/pt unknown
- 2007-07-31 EP EP13190594.5A patent/EP2719385B1/en active Active
- 2007-07-31 RS RS20181413A patent/RS57980B1/sr unknown
- 2007-07-31 WO PCT/US2007/017062 patent/WO2008019010A2/en not_active Ceased
2008
- 2008-12-01 US US12/292,960 patent/US8658663B2/en active Active
2009
- 2009-02-02 IL IL196844A patent/IL196844A/en active IP Right Grant
- 2009-02-10 NO NO20090639A patent/NO343176B1/no not_active IP Right Cessation
2014
- 2014-01-17 US US14/157,992 patent/US8946251B2/en active Active
- 2014-02-06 JP JP2014021171A patent/JP5895009B2/ja not_active Expired - Fee Related
- 2014-05-13 US US14/276,494 patent/US8859576B2/en active Active
- 2014-12-19 US US14/577,227 patent/US9393237B2/en active Active
2016
- 2016-07-15 US US15/211,074 patent/US20170165251A1/en not_active Abandoned
2017
- 2017-10-17 US US15/785,769 patent/US20200268733A9/en not_active Abandoned
2018
- 2018-11-19 CY CY181101219T patent/CY1120867T1/el unknown
- 2018-11-19 HR HRP20181925TT patent/HRP20181925T1/hr unknown
- 2018-11-23 CY CY181101241T patent/CY1120902T1/el unknown

Also Published As

Publication number	Publication date
AU2007282065A1 (en)	2008-02-14
CY1120867T1 (el)	2019-12-11
JP2014077023A (ja)	2014-05-01
WO2008019010A2 (en)	2008-02-14
EP2719385A1 (en)	2014-04-16
US20150335631A1 (en)	2015-11-26
KR20140098865A (ko)	2014-08-08
MX2009001275A (es)	2009-04-16
RS57980B1 (sr)	2019-01-31
KR20090040453A (ko)	2009-04-24
US20180036299A1 (en)	2018-02-08
US20170165251A1 (en)	2017-06-15
JP5846717B2 (ja)	2016-01-20
DK2719385T3 (en)	2018-12-10
US8859576B2 (en)	2014-10-14
US20140235674A1 (en)	2014-08-21
ES2699298T3 (es)	2019-02-08
IL196844A0 (en)	2009-12-24
ME00592B (me)	2011-12-20
EP2068881B1 (en)	2018-08-22
PT2068881T (pt)	2018-11-29
JP5895009B2 (ja)	2016-03-30
JP2009545593A (ja)	2009-12-24
US20140249182A1 (en)	2014-09-04
RS58046B1 (sr)	2019-02-28
CA2659577A1 (en)	2008-02-14
HUE040481T2 (hu)	2019-03-28
EP2068881A4 (en)	2009-09-30
DK2068881T3 (en)	2018-12-10
CN101505759A (zh)	2009-08-12
KR20150132888A (ko)	2015-11-26
HRP20181925T1 (hr)	2019-01-11
SG176452A1 (en)	2011-12-29
ES2698207T3 (es)	2019-02-01
EP2068881A2 (en)	2009-06-17
BRPI0715087A2 (pt)	2015-02-10
US20200268733A9 (en)	2020-08-27
RU2478379C2 (ru)	2013-04-10
PL2719385T3 (pl)	2019-06-28
AU2007282065B2 (en)	2013-05-09
SI2719385T1 (sl)	2019-01-31
NO20090639L (no)	2009-02-25
LT2068881T (lt)	2018-12-10
LT2719385T (lt)	2018-12-27
UA96770C2 (uk)	2011-12-12
HUE040099T2 (hu)	2019-02-28
PT2719385T (pt)	2018-12-04
HRP20181893T1 (hr)	2019-01-11
SI2068881T1 (sl)	2019-01-31
US20090275615A1 (en)	2009-11-05
US20080033050A1 (en)	2008-02-07
NZ574735A (en)	2011-03-31
RU2009107739A (ru)	2010-09-10
CA2659577C (en)	2015-11-24
EP2719385B1 (en)	2018-08-29
US9393237B2 (en)	2016-07-19
NO343176B1 (no)	2018-11-26
WO2008019010A3 (en)	2008-12-24
IL196844A (en)	2015-11-30
US8658663B2 (en)	2014-02-25
CY1120902T1 (el)	2019-12-11
PL2068881T3 (pl)	2019-04-30
US8946251B2 (en)	2015-02-03

Publication	Publication Date	Title
DE60119534D1 (de)	2006-06-14	Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
MX2009005725A (es)	2009-08-24	Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
MY172012A (en)	2019-11-12	Use of dpp iv inhibitors
DK2200616T3 (da)	2013-03-04	Mipo-hæmmere til behandling huntingtons sygdom og multipel system atrofi
EP1933873A4 (en)	2009-12-02	METHOD AND COMPOSITION FOR USE IN THE TREATMENT OF PATIENTS WITH AUTOANTICODRIVER POSITIVE SUFFERING
TN2010000214A1 (en)	2011-11-11	Methods for treating obesity and obesity related diseases and disorders
WO2008156685A3 (en)	2009-03-05	Tendon stem cells
PL3746126T3 (pl)	2024-12-16	Sposoby i kompozycje do leczenia bezdechu sennego lub zwykłego chrapania
DE112009002684A5 (de)	2011-09-29	Verstellbare Unterkieferprotrusionsschiene zur Behandlung von schnarchen und obstruktiver Schlafapnoe
MX2010004450A (es)	2010-05-05	Derivados heterociclo biciclicos y su uso como moduladores de la actividad de gpr119.
MY188365A (en)	2021-12-06	Diagnosis and treatments relating to th2 inhibition
ATE476418T1 (de)	2010-08-15	Benzamidderivate und assoziierte verwendungen
JO3358B1 (ar)	2019-03-13	معالجات حساسية العيون
ATE526991T1 (de)	2011-10-15	Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ME00592A (hr)	2011-12-20	Postupak liječenja termoregulacione disfunkcije paroksetinom
MX2010010799A (es)	2011-03-25	Metodo de diagnostico, prevencion y tratamiento de las enfermedades de la masa osea.
ATE510536T1 (de)	2011-06-15	Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen
NO20072285L (no)	2007-06-13	S-mirtazapin for behandling av hetetokter
EP2001488A4 (en)	2009-11-25	PREVENTION AND TREATMENT OF CANCER AND OTHER DISEASES
NO20073941L (no)	2007-11-05	Dihydroimidazotiazolderivater
FR2901467B1 (fr)	2008-08-15	Prothese anatomique pour le traitement des hernies, telles que hernies inguinales et crurales et autres
EP1812078A4 (en)	2008-06-18	KINASEHEMMER FOR THE TREATMENT OF DIABETES AND ADIPOSITAS
Hess et al.	2016	Modified preparation of the neurovascular bundle in male to female transgender patients
NO20080781L (no)	2008-02-13	GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer
ATE522210T1 (de)	2011-09-15	Zusammensetzungen umfassend alpha-ketoglutarat und ihre verwendung zur modulierung der muskelleistung